Intestinal OCTN2 transporter as a target for enhanced oral delivery for small-molecule prodrug and L

来源 :2015年中国药物制剂大会、中国药学会药剂专业委员会2015年学术年会暨国际控释协会中国分会2015年学术年会 | 被引量 : 0次 | 上传用户:guyuehu11
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  The organic cation/camitine transporter (OCTN2) is a high affinity cation/carnitine transporter widely expressed in human tissues, including skeletal muscle,kidney, brain, heart,and placenta.OCTN2 is essential for L-camitine transport in humans[1]Mutatious of the OCTN2 gene in humans cause primary systemic camitine deficiency, with clinically significant symptoms that include hypoketotic hypoglyce mia,cardiomyopathy, and skeletal myopathy.[2,3] Use of OCTN2 transporter as a target to change the pharmacokinetic properties of drug in the body is a new bright spot in the field of oral drug delivery.
其他文献
  Tumor targeting ligands holds the promise of enhanced antitumor efficacy.Heptapeptide LA7R,identified by screening a mutated phage, was shown to bind specif
会议
会议
  This study aims to develop a green supercritical fluid (SCF) technology in the preparation of inclusion compounds of poor-soluble drug with cyclodextrin.A t
会议
  Despite significant efforts have been made to prevent paraquat (PQ)-induced pulmonary fibrosis,including corticosteroids and immunomodulatory agents, suffic
会议
会议
  Chemical functionalized carbon nanotubes (CNTs) show great potential application in stem cell research—cell substrate, tissue engineering scaffold and stem
会议
会议
会议
  A major challenge in the field of drug delivery is to enhance the transport of therapeutics across biological barriers such as the blood-brain barrier (BBB)
会议